Results 181 to 190 of about 619,448 (301)
Reducing translational science roadblocks to disability research. [PDF]
Bonuck K, Fishman A.
europepmc +1 more source
Mapping the translational science policy ‘valley of death’ [PDF]
Eric M. Meslin +2 more
openalex +1 more source
Erythropoietin administration suppresses hepatic soluble epoxide hydrolase (sEH) expression, leading to increased CYP‐derived epoxides. This is associated with a shift in hepatic macrophage polarization characterized by reduced M1 markers and increased M2 markers, along with reduced hepatic inflammation, suppressed hepatic lipogenesis, and attenuated ...
Takeshi Goda +12 more
wiley +1 more source
Statins for the "SMuRFLess But Inflamed": Silent Vascular Inflammation and the Challenge of Translational Science. [PDF]
Ridker PM.
europepmc +1 more source
The Aging Blood: Cellular Origins, Circulating Drivers, and Therapeutic Potential
As a conduit linking all organs, the blood system both reflects and actively drives systemic aging. This review highlights how circulating pro‐aging and antiaging factors and age‐associated hematopoietic stem cell dysfunction contribute to immunosenescence and multi‐organ decline, positioning the hematopoietic system as a target for aging intervention.
Hanqing He, Jianwei Wang
wiley +1 more source
TRANSLATIONAL SCIENCE IN CHRONIC TENDINOPATHIES
Vijay J Patel, Manish Khanna
openalex +1 more source
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu +8 more
wiley +1 more source
Using the translational science benefits model to evaluate the impact of community-engaged programs. [PDF]
Gomes SM +6 more
europepmc +1 more source

